2,4-DIFLUORO-3-METHYLBENZOIC ACID | CAS:112857-68-8

We serve 2,4-DIFLUORO-3-METHYLBENZOIC ACID CAS:112857-68-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,4-DIFLUORO-3-METHYLBENZOIC ACID

Chemical Name:2,4-DIFLUORO-3-METHYLBENZOIC ACID
CAS.NO:112857-68-8
Synonyms:3-Methyl-2,4-difluorobenzoic acid; 
Benzoic acid,2,4-difluoro-3-methyl;
Molecular Formula:C8H6F2O2
Molecular Weight:172.12900
 
Physical and Chemical Properties:
Density:1.359;
Boiling point:253.1oC;
Flash point:106.9oC;
Index of Refraction:1.511;
 
Specification:
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2,4-DIFLUORO-3-METHYLBENZOIC ACID chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid,2,4-difluoro-3-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-DIFLUORO-3-METHYLBENZOIC ACID Use and application,3-Methyl-2,4-difluorobenzoic acid technical grade,usp/ep/jp grade.


Related News: In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.5-Methylpyridine-2,3-dicarboxylic acid manufacturer In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.4-phenylbutan-2-amine supplier In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate vendor The fine and functional chemicals sector provides new growth drivers.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.